BROMOCRIPTINE

General Schedule
Restricted Benefit

Restriction

Indication: Acromegaly

Restriction

Indication: Parkinson disease

Restriction

Indication: Pathological hyperprolactinaemia

Restriction

Indication: Pathological hyperprolactinaemia

Restriction

Indication: Pathological hyperprolactinaemia

Restriction

Indication: Pathological hyperprolactinaemia
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 120 # of repeats: 5 DPMQ: $52.32 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Parlodel
General Schedule
Restricted Benefit

Restriction

Indication: Acromegaly

Restriction

Indication: Parkinson disease

Restriction

Indication: Pathological hyperprolactinaemia

Restriction

Indication: Pathological hyperprolactinaemia

Restriction

Indication: Pathological hyperprolactinaemia

Restriction

Indication: Pathological hyperprolactinaemia
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 60 # of repeats: 5 DPMQ: $33.06 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Parlodel
bromocriptine 2.5 mg tablet, 30
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: Prevention of the onset of lactation
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 0 DPMQ: $23.42 Max safety net: $24.90 General Patient Charge: $25.00
Available brands
Parlodel